Is Car-T used or approved for any type of solid tumor, or is it only blood cancers at the moment?
Member has chosen to not make this information public.
Member not yet following any Pages.
When endometrial cancer metastasizes, are the mets always the same genetic makeup of the original tumor or is there a possibility of further mutations? In other words, if my original tumor has had genomic testing through an organization like Foundation One, how can I be sure that the mets that have spread to my lungs have the same abnormalities and, therefore, might benefit from an immunotherapy suggested by the genomic testing of the original tumor?